Risk of Alzheimer's disease and duration of NSAID use

Ovid Technologies (Wolters Kluwer Health) - Tập 48 Số 3 - Trang 626-632 - 1997
Walter F. Stewart1,2,3,4,5,6,7,8,9, Claudia H. Kawas1,2,3,4,5,6,7,8,9, María M. Corrada1,2,3,4,5,6,7,8,9, E. Jeffrey Metter
1Athena Neurosciences (Ms. Motter and Dr. Seubert), San Francisco, CA.
2Department of Epidemiology (Dr. Stewart), Johns Hopkins School of Public Health; Department of Neurology (Dr.
3Department of Epidemiology, School of Hygiene and Public Health, 615 N. Wolfe Street, Baltimore, MD 21205.
4Department of Neurosciences (Neurology) (Dr. Galasko), University of California, San Diego and VAMC, San Diego, CA; Department of Neurology (Dr. Clark),
5Emory University, Atlanta, GA
6Hopkins SchooI of Medicine; and Gerontology Research CenterNational Institute on Aging (Drs. Kawas and Metter), Baltimore, MD.
7Neurology V127, VAMC, 3350 La Jolla Village Drive, San Diego, CA 92161.
8University of California, Los Angeles, CA; Department of Neurology (Dr. Green),
9University of Pennsylvania Medical Center, Philadelphia, PA; Department of Neurology (Drs. Chang and Miller),

Tóm tắt

Từ khóa


Tài liệu tham khảo

Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.

10.1073/pnas.82.1.4

Altstiel L, Sperber K. Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:481-495.

10.1016/0167-4838(90)90002-W

10.1016/0197-4580(90)90055-5

Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques: an immunohistochemical study. Acta Neuropathol (Berl) 1982;57:239-252.

McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989;107:341-346.

10.1016/0304-3940(87)90662-8

Anonymous. The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.

Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994;44:227-232.

10.1016/0197-4580(95)80002-9

Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-856.

Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 1995;45:1441-1445.

Kukull WA Larson EG Stergachis A et al. Non-steroidal anti-inflammatory drug use and risk of Alzheimer's disease [abstract]. Neurology 1994;44(suppl 2):A237.

Shock N Greulich R Andres R et al. Normal human aging: the Baltimore Longitudinal Study of Aging (NIH Publication No. 84-2450). Washington DC: US Government Printing Office 1984.

Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.

10.1016/0022-3956(75)90017-5

10.1080/87565648709540360

Kaplan E Goodglass H Weintraub S. The Boston Naming Test. Boston MA: Kaplan and Goodglass 1978.

Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.

Army Individual Test Battery. Manual of directions and scoring. Washington DC: War Department Adjuvant General's Office 1944.

Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 1992;18:70-87.

Morris JC, Mohs R, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.

Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.

Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence using the New Adult Reading Test. Cortex 1978;14:234-244.

10.1001/archneur.1994.00540130015002

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed rev. Washington DC: American Psychiatric Association 1987.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.

Cox DR. Regression models and life tables. J Royal Stat Society, Series B 1972;34:187-220.

10.2307/3575018

Checkoway H Pearce NE Crawford-Brown DJ. Research methods in occupational epidemiology monographs in epidemiology and biostatistics vol 13. New York: Oxford University Press 1989:153-155.

Aspirin Myocardial Infarction Study Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-669.

10.1056/NEJM199407073310101

Paulas HE. Nonsteroidal anti-inflammatory drugs. In: Kelley WN Harris ED Ruddy S Sledge CB eds. A textbook of rheumatology. Philadelphia: WB Saunders 1989.

Corrada M Stewart W Kawas C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease [abstract]. Neurology 1996;46(suppl 2):A433.

Borne RF. Nonsteroidal anti-inflamatory drugs. In: Foye WO Lemke TL Williams DA eds. Principles of medicinal chemistry. 4th ed. Media PA: Williams & Wilkins 1995.

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 48 Số 3

626-632

Thông tin tác giả